Press Room
Tivozanib versus sorafenib
07/05/2012
Tivozanib versus sorafenib as initial targeted therapy for patients with advanced renal cell carcinoma: Results from a phase III randomized, open-label, multicenter trial.
First Patient Dosed in Phase 1b/2a Study of CRLX101 in Combination with Avastin in Renal Cancer
07/05/2012
Having completed enrollment of a 150-patient randomized Phase 2 study in advanced non-small cell lung cancer, Cerulean is beginning to capitalize on the breadth of the CRLX101 opportunity by expanding its development into additional tumor types with several studies conducted by leading investigators.
What is Seattle Care Alliance?
06/30/2012
Our goal, every day, is to turn cancer patients into cancer survivors.
FDA grants priority review to Bayer's regorafenib
06/30/2012
Bayer, the inventor of Aspirin which also makes plastics and pesticides, is also testing regorafenib against a number of tumor types including kidney cancer.
Denise Richards Meets With Cancer Survivors
06/29/2012
Hollywood star puts spotlight on Kidney Cancer Association. Denise Richards, who starred as Dr. Christmas Jones in the James Bond classic, The World is Not Enough, recently hosted a group of kidney cancer survivors and family members at a private luncheon in Hollywood.
Kidney Cancer Association's Survivors Project
06/27/2012
People are living longer with kidney cancer than ever before.
Cost of Medicines to Fall for Thousands of Australians
06/26/2012
Around 45,000 people will benefit from new, cheaper medicines following the Governmentâs approval of eleven new medicines on the Pharmaceutical Benefits Scheme.
Why Biomarker Discovery Is Hard
06/26/2012
What scientists have characterized as the deluge of information that has emerged from genome-scale studies has forced parallel development of new analytical frameworks and tools.
Chromophobe renal cell carcinoma
06/26/2012
The following manuscript will endeavor to provide an overview of this uncommon entity including pathology, epidemiology, genetics, clinical aspects, and current and future treatment options.
Calgary-area cancer ride conquers personal mountains
06/25/2012
It wasnât the greatest weekend to bike more than 200 kilometers, but it was nowhere near the worst thing theyâve been through.
News Feed| Powered by NeonCRM |